Elsevier Inc.

SHERPA: Unknown

People

  1. Van Den Brink
    Van Den Brink
  2. Hanash
    Hanash
  3. Levine
    Levine
  4. Perales
    Perales
  5. Young
    Young
  6. Castro-Malaspina
    Castro-Malaspina
  7. Jakubowski
    Jakubowski
  8. Kernan
    Kernan
  9. O'Reilly
    O'Reilly
  10. Papadopoulos
    Papadopoulos

Groups

  1. Center for Hematologic Malignancies (80)
  2. Executive Committee, Center for Hematologic Malignancies (80)
  3. GSK Faculty (80)
  4. Human Oncology and Pathogenesis Program (80)
  5. Department of Medicine (79)
  6. Hematologic Malignancies, Division of (78)
  7. Sloan Kettering Institute Faculty (45)
  8. Bone Marrow Transplant (44)
  9. Immunology Program Faculty (42)
  10. Tow Center for Developmental Oncology (TCDO) (40)
Search Within
  1. "Center for Hematologic Malignancies"
  2. "Executive Committee, Center for Hematologic Malignancies"
  3. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (40)
  2. Journal Article (33)
  3. Review (3)
  4. Book Section (2)
  5. Editorial (1)
  6. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (80)
  2. Executive Committee, Center for Hematologic Malignancies (80)
  3. GSK Faculty (80)
  4. Human Oncology and Pathogenesis Program (80)
  5. Department of Medicine (79)
  6. Hematologic Malignancies, Division of (78)

More Groups

People
  1. Marcel Van Den Brink (41)
  2. Alan Hanash (23)
  3. James Young (21)
  4. Miguel-Angel Perales (21)
  5. Ross Levine (21)
  6. Ann Jakubowski (18)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (3)
  4. 2021 (5)
  5. 2020 (5)
  6. 2019 (6)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (44)
  2. Hematology/Oncology Clinics of North America (7)
  3. Clinical Lymphoma, Myeloma and Leukemia (6)
  4. European Journal of Cancer (4)
  5. Best Practice and Research: Clinical Haematology (2)
  6. Cell Metabolism (2)

More Publications

Results (80)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Role of tumor microenvironment derived NRG1 in androgen resistance: Implications for a novel prostate cancer treatment strategy
    Meeting Abstract

    Shinder, B.; Mao, N.; Salsabeel, N.; Zhang, Z.; Sawyers, C. L.; Carver, B. S.
    Urologic Oncology: Seminars and Original Investigations (2024)

    Fulltext@MSK | Save
  • Exportin 1 inhibition constraints lineage plasticity and histological transformation through downregulation of SOX2
    Meeting Abstract

    Quintanal-Villalonga, A.; Durani, V.; Sabet, A.; Redin, E.; Kawasaki, K.; Shaffer, M.; Manoj, P.; Sridhar, H.; Haffner, M. C.; Sawyers, C. L.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Profiling the fungal microbiome after fecal microbiota transplantation for graft-versus-host disease: Insights from a phase 1 interventional study
    Journal Article

    van Lier, Y. F.; Rolling, T.; Armijo, G. K.; Zhai, B.; Haverkate, N. J. E.; Meijer, E.; Nur, E.; Blom, B.; Peled, J. U.; van den Brink, M. R. M.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated CLL/SLL: Updated results from the phase 1/2 BRUIN study
    Meeting Abstract

    Coombs, C. C.; Pagel, J. M.; Shah, N. N.; Lamanna, N.; Munir, T.; Lech-Maranda, E.; Eyre, T. A.; Woyach, J. A.; Wierda, W. G.; Cheah, C. Y.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2022)

    Fulltext@MSK | Save
  • Lineage plasticity in prostate cancer depends on FGFR and JAK/STAT inflammatory signaling
    Meeting Abstract

    Chan, J.; Zaidi, S.; Love, J.; Zhao, J.; Setty, M.; Wadosky, K.; Gopalan, A.; Choo, Z. N.; Persad, S.; Chaudhary, O.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Targeting lysine-specific demethylase 1 rescues major histocompatibility complex class I antigen presentation and overcomes programmed death-ligand 1 blockade resistance in SCLC
    Journal Article

    Nguyen, E. M.; Taniguchi, H.; Chan, J. M.; Zhan, Y. A.; Chen, X.; Qiu, J.; de Stanchina, E.; Allaj, V.; Shah, N. S.; Uddin, F.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Pirtobrutinib (LOXO-305), a next-generation, highly selective, non-covalent BTK inhibitor in previously treated CLL/SLL: Results from the phase 1/2 BRUIN study
    Meeting Abstract

    Coombs, C. C.; Pagel, J. M.; Shah, N. N.; Lamanna, N.; Lech-Maranda, E.; Eyre, T. A.; Woyach, J. A.; Wierda, W. G.; Cheah, C. Y.; Roeker, L.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Stories in molecular medicine July 2021
    Miscellaneous

    Abdel-Wahab, O.; Janssen, M.; D'Amico, D.; Freeman, F.
    Trends in Molecular Medicine (2021)

    Fulltext@MSK | Save
  • Therapeutic modulation of RNA splicing in malignant and non-malignant disease
    Review

    El Marabti, E.; Abdel-Wahab, O.
    Trends in Molecular Medicine (2021)

    Fulltext@MSK | Save
  • The new science and concepts that underlie current and future treatments for myeloproliferative neoplasms
    Editorial

    Hoffman, R.; Levine, R.; Mascarenhas, J.; Rampal, R. K.
    Hematology/Oncology Clinics of North America (2021)

    Fulltext@MSK | Save